Skip to main content

stock

ZVRA · ZEVRA THERAPEUTICS, INC.

What ZEVRA THERAPEUTICS, INC. reports to the SEC, read from its filings.

Open in the app

Price

The live ZVRA price and today's change.

Sign in to see this

Chart

Thirty days of daily bars, with signal levels drawn on them.

Sign in to see this

Signals

The latest signal group Nakagai's scanner recorded on ZVRA.

Sign in to see this

Options positioning

Gamma exposure levels from the options market.

Sign in to see this

Technicals

Trend, momentum and volatility gauges per timeframe.

Sign in to see this

What it is

Industry
Pharmaceutical Preparations (SIC 2834)
Filer (SEC EDGAR)
EDGAR filing index
Shares outstanding
59,383,781 as of 2026-07-31 (XBRL frame CY2026Q2I)

Key stats

Valuation

P/E
Locked
P/S
Locked
P/B
Locked
Enterprise value
Locked
EV/EBIT
Locked
FCF yield
Locked

Margins

Gross
—
Operating
60.5%
Net
42.8%

Returns

ROE
26.8%
ROA
19.2%

Health

Current ratio
5.2x
Debt/equity
0.0x

Deep value

NCAV
$166.24M
NCAV per share
$2.80
Price/NCAV
Locked
NNWC
$61.49M
NNWC per share
$1.04
Price/NNWC
Locked

Valuation and the price multiples are built on the live price. Trailing twelve months to 2026-06-30; balance sheet at 2026-06-30.

Sign in to see this

Debt is long-term debt and its current portion. Commercial paper and short-term borrowings are not counted.

Results

Period endRevenueGross profit (not reported by this company)Operating incomeNet incomeFiling
2026-06-30$39.66M—Gross profit: unreported by this company.$16.78M$8.75M
10-Q filed 2026-08-05
2026-03-31$36.22M—Gross profit: unreported by this company.$52.15M$37.89M
10-Q filed 2026-08-05
Assembled from more than one filing; the filing above is only the newest of them.
2025-12-31$34.13M—Gross profit: unreported by this company.$9.31M$12.16M
DEF 14A filed 2026-04-20
Derived: the full year minus the first three quarters, not a figure this filer reported as a quarter.
Assembled from more than one filing; the filing above is only the newest of them.
2025-09-30$26.06M—Gross profit: unreported by this company.$4.14M-$544,000
10-Q filed 2025-11-05
2025-06-30$25.88M—Gross profit: unreported by this company.-$71.04M$74.71M
10-Q filed 2026-08-05
2025-03-31$20.40M—Gross profit: unreported by this company.-$5.36M-$3.10M
10-Q filed 2026-08-05
Assembled from more than one filing; the filing above is only the newest of them.
2024-12-31$12.04M—Gross profit: unreported by this company.-$15.42M-$35.74M
DEF 14A filed 2026-04-20
Derived: the full year minus the first three quarters, not a figure this filer reported as a quarter.
Assembled from more than one filing; the filing above is only the newest of them.
2024-09-30$3.69M—Gross profit: unreported by this company.-$27.31M-$33.23M
10-Q filed 2025-11-05
Assets
$302.71M
Equity
$217.65M

Balance as of 2026-06-30.

Ten years

Fiscal year endRevenueOperating incomeNet incomeFree cash flow
2025-12-31$106.47M-$62.94M$83.23M-$2.43M
2024-12-31$23.61M-$87.00M-$105.51M-$69.67M
2023-12-31$27.46M-$49.60M-$46.05M-$33.83M
2022-12-31$10.16M-$42.56M-$26.77M-$18.81M
2021-12-31$28.65M$7.73M-$8.55M$10.34M
2020-12-31$13.29M-$5.61M-$12.76M-$1.97M
2019-12-31$12.84M-$20.34M-$24.52M-$23.76M
2018-12-31$0-$55.90M-$56.47M-$54.22M
2017-12-31—-$33.37M-$43.39M-$33.28M
2016-12-31—-$37.48M-$16.52M-$30.41M

Company filings

Insiders, politicians and funds

Insider trades, last 90 days

Politician trades, last 90 days

Funds

None of the tracked funds held this at their last 13F.

News

Stories that named ZVRA, and the market events around them.

Sign in to see this

Board

Recent signals

Signals open up here once a member has posted about ZVRA.

Signals are informational.

Posts · 0

No posts yet.

Be the first to say something about ZVRA.

nakagai

Signals on ZVRA come from a rule, not a model.

Nakagai’s scanner records a signal the moment a strategy’s rule matches on the bars. Members read those signals on their own desk, where an agent journals the tape and briefs them in plain English.

Members post on the ZVRA board

This page is not financial advice. Trade at your own judgment and risk. Read the terms that govern posting here.

ZEVRA THERAPEUTICS, INC. (ZVRA): SEC filings, financials and insider trades · Nakagai